Status:
UNKNOWN
Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study
Lead Sponsor:
ELHARRAR Xavier
Conditions:
Coronavirus Infection
Oxygen Deficiency
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The prone position consists of placing the patient on his or her stomach with the head on the side, during sessions lasting several hours a day and could help spontaneous ventilate the patient.
Detailed Description
SARS-CoV-2 is an RNA virus whose tropism for the respiratory system is responsible for many cases of acute respiratory failure. This can lead to acute respiratory distress syndrome (ARDS) requiring or...
Eligibility Criteria
Inclusion
- Patient aged at least 18 years;
- Hospitalized in a COVID unit or intensive care unit;
- Spontaneously breathing and with oxygen therapy with nasal canula, mask or High Flow Oxygen Therapy;
- Requiring oxygen therapy ≥ 1l for Sat ≥ 90%;
- COVID 19 positive in RT-PCR or diagnosis on clinicals symptoms and highly evocatives scannographics lesions in an epidemic period;
- Chest scanner without injection within 72 hours prior to inclusion;
- Bilateral scannographic lesions, including posterior condensations and/or posterior predominance of lesions;
- Patient benefiting from French social security, under any regime
Exclusion
- acute respiratory distress (polypnea \>25 or use of accessory respiratory muscles);
- Alteration of consciousness;
- Active or recent hemoptysis (\<1 month);
- Recent Thrombo-Embolic Venous Disease (\< 1 month);
- Pericardial effusion;
- Pleural effusion of high abundance, clinical or scannographic;
- Chronic back or cervical pain/ history of spinal surgery/ bone metastases;
- Wounds, facial trauma, tracheal, sternal or facial surgery \< 15 days;
- Recent abdominal surgery (\< 1 month);
- Intracranial HyperTension \> 30mmHg;
- Patient deprived of liberty, under guardianship or curatorship;
- Pregnant or lactating woman.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2020
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT04344106
Start Date
April 1 2020
End Date
May 1 2020
Last Update
April 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHI Aix-Pertuis
Aix-en-Provence, France, 13100